The group's principle activities include developing, manufacturing, and commercializing reagents and complete assay kits for the drug discovery and screening markets. The group's products include GPCR Signaling, cell-based assays, kinase arrays, proteases, protein expression and custom EFC assays. The group operates from United States.
